Andrew Skibo

Mr. Skibo has been the Head of Biologics Operations for Blue Water Vaccines, Inc. since June 2021. Mr. Skibo is a seasoned biopharmaceutical operations executive with deep cross-functional experience in international biopharmaceutical manufacturing, process scale-up, internal and external supply chain network design strategy, and major capital project expansions. He has extensive international experience having been responsible for the design and startup of major pharmaceutical manufacturing facilities in the USA, UK, Europe, Russia, Singapore, and China. He is deeply familiar with all aspects of biotechnology product scale-up and launch, having held related roles since the founding days of large-scale biotechnology commercial production. He has a broad understanding of many enterprise operations having held roles in Research and Process Development, Commercial/Business Development, Engineering, and Strategic Planning.

Mr. Skibo served as EVP of Operations at Medimmune, and Head of Biologics Operations at Astra Zeneca for eleven years. He retired from that full-time role in April 2019 but continues to serve as Technical Advisor to EVP Operations, AstraZeneca. In his role, he was responsible for the development and improvement of AstraZeneca’s mono-clonal antibody operations and influenza seasonal and pandemic LAIV Flu operations. He developed the network strategy for these operations and implemented them in ten plants across eight sites (including two new sites) in the USA, UK, Europe, and China. He transformed a previously challenging regulatory quality environment (warning letter) to best-in-class status. He oversaw the development of four BLA’s and biologics product launches from 2017 to 2019, and has held related roles for nine product launches in his career.